Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
ARQL

ArQule

$3.68

0.16 (4.55%)

09:17
01/16/19
01/16
09:17
01/16/19
09:17
Initiation
ArQule initiated at Empire »

ArQule initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARQL

ArQule

$3.27

-0.22 (-6.30%)

07:05
01/09/19
01/09
07:05
01/09/19
07:05
Hot Stocks
Basilea announces 'positive' interim results from Phase 2 study of derazantinib »

ArQule's partner,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DLTR

Dollar Tree

$98.66

5.77 (6.21%)

, LLY

Eli Lilly

$115.98

1.33 (1.16%)

13:02
01/07/19
01/07
13:02
01/07/19
13:02
On The Fly
Fly Intel: Wall Street's top stories at midday »

Stocks opened little…

DLTR

Dollar Tree

$98.66

5.77 (6.21%)

LLY

Eli Lilly

$115.98

1.33 (1.16%)

LOXO

Loxo Oncology

$231.60

91.78 (65.64%)

AAPL

Apple

$147.47

-0.8 (-0.54%)

SSNLF

Samsung

$0.00

(0.00%)

AGIO

Agios Pharmaceuticals

$50.39

3.62 (7.74%)

ARQL

ArQule

$3.34

0.15 (4.70%)

ARRY

Array BioPharma

$17.28

1.57 (9.99%)

BPMC

Blueprint Medicines

$61.96

8.48 (15.86%)

KURA

Kura Oncology

$15.87

0.75 (4.96%)

MRTX

Mirati Therapeutics

$46.85

1.91 (4.25%)

LXFT

Luxoft

$57.50

25.795 (81.36%)

DXC

DXC Technology

$57.53

0.2 (0.35%)

SAGE

Sage Therapeutics

$141.04

43.6 (44.75%)

PCG

PG&E

$18.99

-5.405 (-22.16%)

HCLP

Hi-Crush Partners

$3.67

-0.68 (-15.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

  • 07

    Jan

  • 07

    Jan

  • 07

    Jan

  • 07

    Jan

  • 07

    Jan

  • 08

    Jan

  • 14

    Jan

  • 17

    Jan

  • 28

    Jan

  • 10

    Feb

  • 19

    Mar

  • 18

    May

LOXO

Loxo Oncology

$139.82

8.92 (6.81%)

, LLY

Eli Lilly

$114.65

3.36 (3.02%)

09:13
01/07/19
01/07
09:13
01/07/19
09:13
Recommendations
Loxo Oncology, Eli Lilly, Agios Pharmaceuticals, ArQule, Array BioPharma, Blueprint Medicines, Kura Oncology, Mirati Therapeutics analyst commentary at Piper Jaffray »

Piper Jaffray views price…

LOXO

Loxo Oncology

$139.82

8.92 (6.81%)

LLY

Eli Lilly

$114.65

3.36 (3.02%)

AGIO

Agios Pharmaceuticals

$46.77

0.9 (1.96%)

ARQL

ArQule

$3.19

0.46 (16.85%)

ARRY

Array BioPharma

$15.71

1.02 (6.94%)

BPMC

Blueprint Medicines

$53.48

4.69 (9.61%)

KURA

Kura Oncology

$15.12

0.67 (4.64%)

MRTX

Mirati Therapeutics

$44.94

1.03 (2.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

  • 07

    Jan

  • 07

    Jan

  • 14

    Jan

  • 17

    Jan

  • 28

    Jan

  • 18

    May

Over a month ago
GSK

GlaxoSmithKline

$38.59

-3.28 (-7.83%)

, TSRO

Tesaro

$73.48

27.2 (58.77%)

12:09
12/03/18
12/03
12:09
12/03/18
12:09
On The Fly
Fly Intel: Wall Street's top stories at midday »

Stocks soared at the open…

GSK

GlaxoSmithKline

$38.59

-3.28 (-7.83%)

TSRO

Tesaro

$73.48

27.2 (58.77%)

TRCO

Tribune Media

$44.21

3.97 (9.87%)

NXST

Nexstar

$84.50

1.86 (2.25%)

GBT

Global Blood Therapeutics

$45.84

14.28 (45.25%)

NBEV

New Age Beverages

$5.18

0.56 (12.12%)

AGIO

Agios Pharmaceuticals

$58.97

-6.84 (-10.39%)

ARQL

ArQule

$3.33

-0.37 (-10.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

  • 03

    Dec

  • 03

    Dec

  • 03

    Dec

  • 03

    Dec

  • 03

    Dec

  • 03

    Dec

  • 04

    Dec

ARQL

ArQule

$3.70

0.04 (1.09%)

08:25
12/03/18
12/03
08:25
12/03/18
08:25
Conference/Events
ArQule to hold a conference call »

Management discusses…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

ARQL

ArQule

$3.70

0.04 (1.09%)

07:11
12/03/18
12/03
07:11
12/03/18
07:11
Hot Stocks
ArQule annnounces ARQ 531 demonstrates anti-tumor activity in Phase 1 study »

ArQule presented…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

ARQL

ArQule

$3.70

0.04 (1.09%)

04:55
12/03/18
12/03
04:55
12/03/18
04:55
Conference/Events
ArQule to hold a conference call »

Management discusses…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

ARQL

ArQule

$3.62

0.15 (4.32%)

14:13
11/29/18
11/29
14:13
11/29/18
14:13
Conference/Events
ArQule to hold a conference call »

Management discusses…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Dec

ARQL

ArQule

$3.99

0.07 (1.79%)

16:02
11/16/18
11/16
16:02
11/16/18
16:02
Hot Stocks
ArQule presents clinical, preclinical data for ARQ 751 »

ArQule announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 01

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.